395 related articles for article (PubMed ID: 21398221)
21. ZFP521 regulates murine hematopoietic stem cell function and facilitates MLL-AF9 leukemogenesis in mouse and human cells.
Garrison BS; Rybak AP; Beerman I; Heesters B; Mercier FE; Scadden DT; Bryder D; Baron R; Rossi DJ
Blood; 2017 Aug; 130(5):619-624. PubMed ID: 28615219
[TBL] [Abstract][Full Text] [Related]
22. The role of DOT1L in the maintenance of leukemia gene expression.
Wang X; Chen CW; Armstrong SA
Curr Opin Genet Dev; 2016 Feb; 36():68-72. PubMed ID: 27151433
[TBL] [Abstract][Full Text] [Related]
23. CBX8, a polycomb group protein, is essential for MLL-AF9-induced leukemogenesis.
Tan J; Jones M; Koseki H; Nakayama M; Muntean AG; Maillard I; Hess JL
Cancer Cell; 2011 Nov; 20(5):563-75. PubMed ID: 22094252
[TBL] [Abstract][Full Text] [Related]
24. Small-molecule inhibitor of AF9/ENL-DOT1L/AF4/AFF4 interactions suppresses malignant gene expression and tumor growth.
Wu F; Nie S; Yao Y; Huo T; Li X; Wu X; Zhao J; Lin YL; Zhang Y; Mo Q; Song Y
Theranostics; 2021; 11(17):8172-8184. PubMed ID: 34373735
[TBL] [Abstract][Full Text] [Related]
25. The RNA-binding protein IGF2BP3 is critical for MLL-AF4-mediated leukemogenesis.
Tran TM; Philipp J; Bassi JS; Nibber N; Draper JM; Lin TL; Palanichamy JK; Jaiswal AK; Silva O; Paing M; King J; Katzman S; Sanford JR; Rao DS
Leukemia; 2022 Jan; 36(1):68-79. PubMed ID: 34321607
[TBL] [Abstract][Full Text] [Related]
26. MLL1 and DOT1L cooperate with meningioma-1 to induce acute myeloid leukemia.
Riedel SS; Haladyna JN; Bezzant M; Stevens B; Pollyea DA; Sinha AU; Armstrong SA; Wei Q; Pollock RM; Daigle SR; Jordan CT; Ernst P; Neff T; Bernt KM
J Clin Invest; 2016 Apr; 126(4):1438-50. PubMed ID: 26927674
[TBL] [Abstract][Full Text] [Related]
27. Elucidating the Importance of DOT1L Recruitment in MLL-AF9 Leukemia and Hematopoiesis.
Grigsby SM; Friedman A; Chase J; Waas B; Ropa J; Serio J; Shen C; Muntean AG; Maillard I; Nikolovska-Coleska Z
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33562706
[No Abstract] [Full Text] [Related]
28. Cooperative gene activation by AF4 and DOT1L drives MLL-rearranged leukemia.
Okuda H; Stanojevic B; Kanai A; Kawamura T; Takahashi S; Matsui H; Takaori-Kondo A; Yokoyama A
J Clin Invest; 2017 May; 127(5):1918-1931. PubMed ID: 28394257
[TBL] [Abstract][Full Text] [Related]
29. Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis.
Daser A; Rabbitts TH
Genes Dev; 2004 May; 18(9):965-74. PubMed ID: 15132992
[No Abstract] [Full Text] [Related]
30. Leukemic transformation of hematopoietic progenitors by MLL-GAS7 in the absence of Hoxa7 or Hoxa9.
So CW; Karsunky H; Wong P; Weissman IL; Cleary ML
Blood; 2004 Apr; 103(8):3192-9. PubMed ID: 15070702
[TBL] [Abstract][Full Text] [Related]
31. Stress hematopoiesis reveals abnormal control of self-renewal, lineage bias, and myeloid differentiation in Mll partial tandem duplication (Mll-PTD) hematopoietic stem/progenitor cells.
Zhang Y; Yan X; Sashida G; Zhao X; Rao Y; Goyama S; Whitman SP; Zorko N; Bernot K; Conway RM; Witte D; Wang QF; Tenen DG; Xiao Z; Marcucci G; Mulloy JC; Grimes HL; Caligiuri MA; Huang G
Blood; 2012 Aug; 120(5):1118-29. PubMed ID: 22740449
[TBL] [Abstract][Full Text] [Related]
32. MLL is essential for NUP98-HOXA9-induced leukemia.
Shima Y; Yumoto M; Katsumoto T; Kitabayashi I
Leukemia; 2017 Oct; 31(10):2200-2210. PubMed ID: 28210005
[TBL] [Abstract][Full Text] [Related]
33. Ets1 Plays a Critical Role in MLL/EB1-Mediated Leukemic Transformation in a Mouse Bone Marrow Transplantation Model.
Fu JF; Yen TH; Huang YJ; Shih LY
Neoplasia; 2019 May; 21(5):469-481. PubMed ID: 30974389
[TBL] [Abstract][Full Text] [Related]
34. MLL-AF9 and MLL-ENL alter the dynamic association of transcriptional regulators with genes critical for leukemia.
Monroe SC; Jo SY; Sanders DS; Basrur V; Elenitoba-Johnson KS; Slany RK; Hess JL
Exp Hematol; 2011 Jan; 39(1):77-86.e1-5. PubMed ID: 20854876
[TBL] [Abstract][Full Text] [Related]
35. Design, Synthesis, and Biological Evaluations of DOT1L Peptide Mimetics Targeting the Protein-Protein Interactions between DOT1L and MLL-AF9/MLL-ENL.
Yuan Y; Du L; Tan R; Yu Y; Jiang J; Yao A; Luo J; Tang R; Xiao Y; Sun H
J Med Chem; 2022 Jun; 65(11):7770-7785. PubMed ID: 35612819
[TBL] [Abstract][Full Text] [Related]
36. Plzf drives MLL-fusion-mediated leukemogenesis specifically in long-term hematopoietic stem cells.
Ono R; Masuya M; Nakajima H; Enomoto Y; Miyata E; Nakamura A; Ishii S; Suzuki K; Shibata-Minoshima F; Katayama N; Kitamura T; Nosaka T
Blood; 2013 Aug; 122(7):1271-83. PubMed ID: 23838347
[TBL] [Abstract][Full Text] [Related]
37. Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor.
Daigle SR; Olhava EJ; Therkelsen CA; Majer CR; Sneeringer CJ; Song J; Johnston LD; Scott MP; Smith JJ; Xiao Y; Jin L; Kuntz KW; Chesworth R; Moyer MP; Bernt KM; Tseng JC; Kung AL; Armstrong SA; Copeland RA; Richon VM; Pollock RM
Cancer Cell; 2011 Jul; 20(1):53-65. PubMed ID: 21741596
[TBL] [Abstract][Full Text] [Related]
38. Essential role of PR-domain protein MDS1-EVI1 in MLL-AF9 leukemia.
Zhang Y; Owens K; Hatem L; Glass CH; Karuppaiah K; Camargo F; Perkins AS
Blood; 2013 Oct; 122(16):2888-92. PubMed ID: 24021671
[TBL] [Abstract][Full Text] [Related]
39. The role of menin in hematopoiesis.
Maillard I; Hess JL
Adv Exp Med Biol; 2009; 668():51-7. PubMed ID: 20175452
[TBL] [Abstract][Full Text] [Related]
40. PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease.
Li Z; Chen P; Su R; Hu C; Li Y; Elkahloun AG; Zuo Z; Gurbuxani S; Arnovitz S; Weng H; Wang Y; Li S; Huang H; Neilly MB; Wang GG; Jiang X; Liu PP; Jin J; Chen J
Cancer Res; 2016 Feb; 76(3):619-29. PubMed ID: 26747896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
